Abstract
A cross-sectional study was designed with high-school students. The study’s objective was to establish the relationship between cannabis smoking and academic achievement, adjusted for clinically important depressive symptoms and family dysfunction. The authors quantified lifetime cannabis smoking, perception of academic achievement, clinically important depressive symptoms, and family dysfunction. It was computed crude association between cannabis smoking and academic achievement and adjusted by clinically important depressive symptoms and family dysfunction. A total of 1,462 students between 13 and 17 years participated in the research; 11.63% reported lifetime cannabis smoking; 30.78%, poor-fair academic achievement; 7.05%, clinically important depressive symptoms; and 76.06%, family dysfunction. The lifetime cannabis smoking was significantly associated with poor-fair academic achievement after adjusting for clinically important depressive symptoms and family dysfunction (OR = 1.61, 95%CI 1.16 – 2.24). In conclusion, lifetime cannabis smoking is related to poor-fair academic achievement among high-school students in Santa Marta, Colombia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Research Vice-rectory of the Universidad del Magdalena financed this research through Resolution 0347 of 2018 in the name of Adalberto Campo-Arias (Call Fonciencias 2017).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Ethical Board of the Universidad del Magdalena, Santa Marta, Colombia approved the project in ordinary session on July 12, 2018.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: yegsonperezm{at}unimagdalena.edu.co.
Email: gceballos{at}unimagdalena.edu.co.
Author note
Data availability statement: The data supporting this study’s findings are available from the corresponding author upon reasonable request.
Data Availability
The data supporting this study's findings are available from the corresponding author upon reasonable request.
